Taiwan
· Delayed Price · Currency is TWD EirGenix Statistics
Total Valuation
EirGenix has a market cap or net worth of TWD 25.45 billion. The enterprise value is 21.02 billion.
| Market Cap | 25.45B |
| Enterprise Value | 21.02B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EirGenix has 306.21 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Shares Outstanding | 306.21M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.42% |
| Owned by Institutions (%) | 12.44% |
| Float | 238.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.40 |
| PB Ratio | 2.62 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -24.96 |
| EV / Sales | 18.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.74 |
Financial Position
The company has a current ratio of 13.25, with a Debt / Equity ratio of 8.69.
| Current Ratio | 13.25 |
| Quick Ratio | 11.54 |
| Debt / Equity | 8.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.59 |
| Interest Coverage | -123.65 |
Financial Efficiency
Return on equity (ROE) is -8.40% and return on invested capital (ROIC) is -6.15%.
| Return on Equity (ROE) | -8.40% |
| Return on Assets (ROA) | -5.93% |
| Return on Capital (ROIC) | -6.15% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.10 |
| Inventory Turnover | 1.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.36% in the last 52 weeks. The beta is 0.62, so EirGenix's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -11.36% |
| 50-Day Moving Average | 86.42 |
| 200-Day Moving Average | 89.67 |
| Relative Strength Index (RSI) | 43.30 |
| Average Volume (20 Days) | 316,627 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EirGenix had revenue of TWD 1.13 billion and -842.30 million in losses. Loss per share was -2.76.
| Revenue | 1.13B |
| Gross Profit | 256.07M |
| Operating Income | -1.05B |
| Pretax Income | -840.58M |
| Net Income | -842.30M |
| EBITDA | -788.58M |
| EBIT | -1.05B |
| Loss Per Share | -2.76 |
Balance Sheet
The company has 5.27 billion in cash and 843.05 million in debt, giving a net cash position of 4.42 billion or 14.44 per share.
| Cash & Cash Equivalents | 5.27B |
| Total Debt | 843.05M |
| Net Cash | 4.42B |
| Net Cash Per Share | 14.44 |
| Equity (Book Value) | 9.70B |
| Book Value Per Share | 31.67 |
| Working Capital | 6.10B |
Cash Flow
In the last 12 months, operating cash flow was -593.56 million and capital expenditures -832.82 million, giving a free cash flow of -1.43 billion.
| Operating Cash Flow | -593.56M |
| Capital Expenditures | -832.82M |
| Free Cash Flow | -1.43B |
| FCF Per Share | -4.66 |
Margins
Gross margin is 22.58%, with operating and profit margins of -92.82% and -74.27%.
| Gross Margin | 22.58% |
| Operating Margin | -92.82% |
| Pretax Margin | -74.12% |
| Profit Margin | -74.27% |
| EBITDA Margin | -69.53% |
| EBIT Margin | -92.82% |
| FCF Margin | -125.77% |
Dividends & Yields
EirGenix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.45% |
| Shareholder Yield | -0.45% |
| Earnings Yield | -3.32% |
| FCF Yield | -5.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |